Sleeping pills including Xanax and Valium TREBLE the risk of lung cancer

Norwegian Institute of Public Health scientists found a slight increase in the risk of all types of cancer with sleeping tablets, but a 'worrying' rise in risk with respiratory cancers.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

LUNG CANCER symptoms include difficulty breathing, headaches, and persistent chest pain. But you could also be at risk of an advanced tumour if you develop a subtle sign on your eyes. Could you be at risk of lung cancer?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
microRNA-23B inhibits non-small cell lung cancer proliferation, invasion and migration via downregulation of RUNX2 and inhibition of Wnt/Β-catenin signaling pathway. J Biol Regul Homeost Agents. 2020 Jun 04;34(3): Authors: Wang HX, Wang XY, Fei JW, Li FH, Han J, Qin X Abstract Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancer cases. MicroRNAs (miRNAs/miRs) have been reported to play significant roles in the progression of human tumors, however, the expression and biological role of miR-23b in NSCLC remains elusive. Underexpression of miR-23b was detected in NSCLC tissues...
Source: Journal of Biological Regulators and Homeostatic Agents - Category: Biomedical Science Tags: J Biol Regul Homeost Agents Source Type: research
Purpose of review There are several first-line systemic therapy options for patients with newly diagnosed stage IV non-small-cell lung cancer. Targeted therapy with tyrosine kinase inhibitors provide a good first option for some. Unfortunately, most patients do not have an alteration for which there is an available tyrosine kinase inhibitor. For these patients there are immunotherapy and chemoimmunotherapy options; however, there is debate about how to choose amongst these treatments for a given individual. This review attempts to simplify this decision-making process. Recent findings The data on first-line immunother...
Source: Current Opinion in Pulmonary Medicine - Category: Respiratory Medicine Tags: NEOPLASMS OF THE LUNG: Edited by Alan M. Fein and David E. Ost Source Type: research
Purpose of review Patients with lung cancer are particularly vulnerable to lung injury associated with immune checkpoint inhibition and often present with more frequent and more severe manifestations of lung disease compared to patients with other tumor types. The present review explores the reasons for increased susceptibility to immune checkpoint-related lung injury among this group of patients and focuses on the current knowledge of the clinical and radiologic manifestations of lung injury associated with immune checkpoint blockade and current treatment strategies. Recent findings Recent investigations have shown t...
Source: Current Opinion in Pulmonary Medicine - Category: Respiratory Medicine Tags: NEOPLASMS OF THE LUNG: Edited by Alan M. Fein and David E. Ost Source Type: research
Purpose of review The essential role of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in lung cancer diagnosis and staging is now well established. With a growing body of evidence seen over the last decade, the objective of this article was to review the newest findings, provide evidence-based guidance to clinicians and identify areas for future research related to EBUS-TBNA and staging in lung cancer. Recent findings Recent literature regarding EBUS-TBNA for lung cancer staging was reviewed, with a focus on evidence published subsequent to the 2016 guideline on technical aspects of EBUS...
Source: Current Opinion in Pulmonary Medicine - Category: Respiratory Medicine Tags: NEOPLASMS OF THE LUNG: Edited by Alan M. Fein and David E. Ost Source Type: research
Conditions:   Carcinoma;   Lung Cancer;   NSCLC;   Lung Neoplasms Intervention:   Diagnostic Test: Breath test Sponsors:   Peking University People's Hospital;   Beijing Haidian Hospital;   Aerospace 731 Hospital;   Beijing Breatha Biological Technology Co., Ltd, Beijing Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Lung Cancer Intervention:   Sponsor:   Collège des Pneumologues des Hôpitaux Généraux Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Carcinoma;   Lung Cancer;   NSCLC;   Lung Neoplasms Intervention:   Diagnostic Test: Breath test Sponsors:   Peking University People's Hospital;   Beijing Haidian Hospital;   Aerospace 731 Hospital;   Beijing Breatha Biological Technology Co., Ltd, Beijing Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Lung Cancer Intervention:   Sponsor:   Collège des Pneumologues des Hôpitaux Généraux Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Small Cell Lung Cancer Limited Stage Intervention:   Drug: Toripalimab Sponsors:   Sun Yat-sen University;   The First Affiliated Hospital of Guangzhou Medical University;   Guangzhou Panyu Central Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alprazolam | Cancer | Cancer & Oncology | Diazepam | Health | International Medicine & Public Health | Lung Cancer | Respiratory Medicine | Valium | Xanax